SCHEMBL6137764

SCHEMBL6137764

CC(C)(C)OC(=O)N1C(=O)C2CCCC2c2ccc(-c3ccco3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.45
GABRA1 P14867 3/20 0.43
GABRG2 P18507 3/20 0.43
GABRB3 P28472 3/20 0.43
GABRA5 P31644 3/20 0.43
GABRA3 P34903 3/20 0.43
GABRA2 P47869 3/20 0.43
GABRA6 Q16445 3/20 0.43
GABRA4 P48169 2/20 0.43
TGFBR1 P36897 2/20 0.41
SLC6A4 P31645 5/20 0.37
RECQL P46063 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6137592 0.79 BCHE (0.47) GPR119ALDH1A1CYP2C19KDM4EKMT2A
SCHEMBL6137757 0.78 GPR119 (0.41) GPR119GABRA1GABRG2GABRB3GABRA5
SCHEMBL6137803 0.73 ALDH1A1 (0.39) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6137318 0.73 CDK1 (0.42) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6137336 0.73 GPR119 (0.37) GPR119TDP1KDM4ETSHRKMT2A
SCHEMBL6137535 0.71 FKBP1A (0.32) TDP1KDM4E
SCHEMBL6069300 0.70 SMN1; SMN2 (0.37) ALDH1A1
SCHEMBL4936743 0.65 GPR119 (0.50) GPR119GABRA1GABRG2GABRB3GABRA5
SCHEMBL6069508 0.65 TDP2 (0.42) RECQLHSD17B10TDP1ALDH1A1CYP2D6
SCHEMBL13118683 0.63 GPR119 (0.64) GPR119ALDH1A1CYP2C19MEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1129077-B9 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-07-20 EP disclosed
EP-1129077-B1 FLUORINATED 3,4-DIHYDROQUINOLINE DERIVATIVES USED AS NOS INHIBITORS SCHERING AG (DE) 2005-04-20 EP disclosed
US-6579883-B1 Nitrogen monoxide synthases; 4-amino-8-bromo-3a-fluoro-2,3,3a,9b-tetrahydro-1H-cyclopenta (c) quinoline; neurodegenerative, autoimmune, cardiovascular diseases SCHERING AKTIENGESELLSCHAFT (DE) 2003-06-17 US disclosed